258 related articles for article (PubMed ID: 4351085)
1. [Endocrine exophthalmos].
Lavergne G; Winand R
Bull Soc Belge Ophtalmol; 1973; 163(1):1-170. PubMed ID: 4351085
[No Abstract] [Full Text] [Related]
2. [Treatment of endocrine ophthalmopathy].
Raith L
Z Allgemeinmed; 1973 Dec; 49(35):1727-30. PubMed ID: 4131142
[No Abstract] [Full Text] [Related]
3. [Graves-Basedow type ophthalmopathy and primary hypothyroidism].
Cathelineau G; Fribourg-Desi M
Nouv Presse Med; 1974 Sep; 3(32):1995-8. PubMed ID: 4372586
[No Abstract] [Full Text] [Related]
4. [Concept of endocrine ophthalmopathies].
Heberting HJ; Schwarzmann E
Z Gesamte Inn Med; 1974 Sep; 29(17):712-5. PubMed ID: 4141190
[No Abstract] [Full Text] [Related]
5. Endocrine exophthalmos.
Wilkins RB; Sessions RB
Int Ophthalmol Clin; 1970; 10(1):71-84. PubMed ID: 5537363
[No Abstract] [Full Text] [Related]
6. Endocrine exophthalmos.
Havard CW
Br Med J; 1972 Feb; 1(5796):360-3. PubMed ID: 4550413
[No Abstract] [Full Text] [Related]
7. [Endocrine edematous exophthalmos and orbital venous circulatory blocking. Value of phlebography].
Aron-Rosa D; Morax PV; Aron JJ; Metzger J
Ann Ocul (Paris); 1970 Jan; 203(1):1-24. PubMed ID: 4314650
[No Abstract] [Full Text] [Related]
8. Advances in the treatment of endocrine disorders.
Hall R
Practitioner; 1969 Oct; 203(216):494-500. PubMed ID: 4311092
[No Abstract] [Full Text] [Related]
9. Endocrine exophthalmos: an immunologic aberration.
Kaplan HJ
Ophthalmic Semin; 1977; 2(2):203-46. PubMed ID: 327376
[No Abstract] [Full Text] [Related]
10. [Unusual course of a malignant exophthalmos].
Schindler H
MMW Munch Med Wochenschr; 1975 Apr; 117(16):669-70. PubMed ID: 805926
[TBL] [Abstract][Full Text] [Related]
11. [Endocrine ophthalmopathy].
Pickardt CR; Boergen KP; Heinze HG
Internist (Berl); 1974 Oct; 15(10):497-505. PubMed ID: 4611949
[No Abstract] [Full Text] [Related]
12. Mechanisms of Graves' disease and endocrine exophthalmos.
Anderson DR
Am J Ophthalmol; 1969 Jul; 68(1):46-57. PubMed ID: 4895778
[No Abstract] [Full Text] [Related]
13. [Malignant ophthalmopathy. Results of corticosteroid therapy associated with a cytotoxic immunosuppressive agent].
Aquino CS; Coelho JC; Tendrich M; Gonçalves Filho CA; Pinto JC; Pontes JP
AMB Rev Assoc Med Bras; 1978 Apr; 24(4):115-8. PubMed ID: 308242
[No Abstract] [Full Text] [Related]
14. Long-acting thyroid stimulator and exophthalmos.
Burke G
Ann Intern Med; 1969 May; 70(5):1045-6. PubMed ID: 4181434
[No Abstract] [Full Text] [Related]
15. The ocular and orbital circulations in dysthyroid ophthalmopathy.
Cant JS; Wilson TM
Trans Ophthalmol Soc U K (1962); 1974 Jul; 94(2):416-29. PubMed ID: 4549701
[No Abstract] [Full Text] [Related]
16. Pathogenesis and treatment of endocrine exophthalmos.
Haddad HM
Int Surg; 1973 Jul; 58(7):482-4. PubMed ID: 4740436
[No Abstract] [Full Text] [Related]
17. [Thyroid dysfunction in the aged].
Marañón Cabello A
An Med Interna; 2000 Jan; 17(1):1-4. PubMed ID: 10730396
[No Abstract] [Full Text] [Related]
18. Long-term prognosis in malignant exophthalmos.
Riise R
Acta Ophthalmol (Copenh); 1970; 48(4):634-43. PubMed ID: 5536710
[No Abstract] [Full Text] [Related]
19. [On the pathogenetic significance of hypophyseal factors in endocrine ophthalmopathy].
Mertz DP; Stelzer M
Dtsch Med Wochenschr; 1969 Jan; 94(1):27-32. PubMed ID: 5818126
[No Abstract] [Full Text] [Related]
20. Pretibial myxedema and nonthyrotoxic thyroid disease.
Lynch PJ; Maize JC; Sisson JC
Arch Dermatol; 1973 Jan; 107(1):107-11. PubMed ID: 4118738
[No Abstract] [Full Text] [Related]
[Next] [New Search]
